As pharma companies struggle to define the “new normal,” what does it mean for healthcare agencies trying to depict patients successfully managing their diseases, i.e., living more “normal” lives? When concepting for new campaigns, what new creative considerations should be discussed in the shadow of COVID-19? Here are some thoughts from Stephen Neale, EVP, Chief Creative Officer, AbelsonTaylor.